Drug & supplement interaction

Arrach + Lorlatinib

Lorlatinib brand name: Lorbrena.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Arrach and Lorlatinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Arrach and Lorlatinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Lorlatinib and Arrach in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Arrach safety at a glance

Arrach overall Not established There is very little modern safety data on Arrach, so use cannot be considered proven safe.
Pregnancy Avoid Traditionally linked to menstrual effects, so it should be avoided during pregnancy.
Breastfeeding Avoid No safety information is available, so avoid use while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Lorlatinib and Arrach? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Lorlatinib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Lorlatinib is filed under 3 classifications — cytochrome p450 3a4 (cyp3a4) inducers, cytochrome p450 3a4 (cyp3a4) substrates, oral drugs. Arrach has documented interactions with 1 drug class — the most serious being photosensitizing drugs (moderate) — and none of Lorlatinib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Arrach Does Interact With Other Medications

Arrach has 335 moderate known drug interactions in our database — Lorlatinib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Arrach

Covers the 2,830 medications we’ve checked against Arrach. Pick one to open its full report.

What to actually watch for

What Lorlatinib’s Own FDA Label Lists

This is not an interaction — none of it involves Arrach. These are the most notable effects listed in the ADVERSE REACTIONS section of Lorlatinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • Mania or an unusually elevated mood Worth acting on
  • Loss of vision Worth acting on
  • Low magnesium Worth acting on
  • Thoughts of self-harm Worth acting on
  • Muscle weakness Worth acting on
  • Memory problems Worth acting on
  • High potassium Worth acting on
  • Unsteadiness Worth acting on
  • A heart attack Worth acting on
  • Blood clots Worth acting on

Showing the 10 most notable of 48 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 6,977 voluntary FDA FAERS reports for Lorlatinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Arrach’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Arrach side to compare — that is a limit of the record, not a statement that Arrach has no side effects.

Everything else you take

See Every Supplement That Interacts With Lorlatinib

This page covers Arrach only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Lorlatinib page lists 153 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 110 moderate · 40 minor.

From our pharmacist’s overview on the Lorlatinib page

“Lorlatinib (Lorbrena) treats ALK-positive lung cancer, and keeping its blood level steady is central to keeping the cancer controlled, so I treat this list with genuine vigilance. Nearly all 153 interactions on file run through CYP3A4, the enzyme that clears the drug.”

Reviewed by 2 · Jul 18, 2026

Open the Lorlatinib interaction page

How much people look this up

Where Arrach and Lorlatinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Arrach
Steady interest

#897 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Lorlatinib
Steady interest

#2,010 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Arrach reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Arrach and Lorlatinib records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Arrach

What is Arrach?

Arrach
  • Painful menstruation
  • Nervous complaints
  • Digestive upset
  • Wound care
  • Insect repellent

Arrach (Chenopodium vulvaria) is a strong-smelling European herb that has been used in traditional folk medicine, mainly for menstrual and nervous complaints. There is very little modern scientific evidence to show that it works or is safe, so it is not recommended, especially during pregnancy or breastfeeding. Talk to your pharmacist or doctor before using any herbal product.

Chenopodium vulvaria · Amaranthaceae · Leaves and aerial (above-ground) parts · Dried herb, tea/infusion, and topical preparations

An interaction check asks whether these two react with each other — it does not ask whether Arrach is a good idea for someone in your situation. Here is what our Arrach record says about it on its own.

Arrach: dosing

There is no established or standardized dose for Arrach. It is not a common commercial supplement, and reliable dosing information from modern sources does not exist.If you ever come across a product containing Arrach, follow the directions on the label and do not exceed them.

From our Arrach monograph — the full record covers uses, side effects and every documented interaction.

Read the full Arrach monograph & all interactions
Medication

About Lorlatinib

What Is Lorlatinib Used For?

Brand name: Lorbrena

Lorbrena (lorlatinib) is used to treat adults with metastatic non-small cell lung cancer (NSCLC) — meaning lung cancer that has spread — when lab testing confirms the tumor is ALK-positive (has a specific gene change that drives cancer growth). Patients must be tested with an FDA-approved diagnostic test before starting treatment.

Lorbrena has been studied in patients who have not yet received treatment for advanced disease, as well as in patients whose cancer progressed on other ALK-targeting medicines.

Most-Reported Side Effects for Lorlatinib

From FAERS, the FDA’s public side-effect reporting system (6,977 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Neoplasm progression 621 reports
Hallucination 404 reports
Weight increased 399 reports
Blood cholesterol increased 348 reports
Dyspnea 270 reports
See full Lorlatinib drug information
Keep checking

Other Drugs & Arrach

Browse every other medication we’ve checked against Arrach — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
335Moderate
0Minor
2,494No known interaction
Moderate

335 interactions

Showing 60 of 335 moderate interactions — see all 335 on the Arrach page.

No interaction 2,494 drugs checked — show the list
Evidence & sources

Arrach References

The 1 references that drive our Arrach monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Arrach and Lorlatinib Together: Common Questions

Is it safe to take Arrach with Lorlatinib?
We do not list a known interaction between Arrach and Lorlatinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
How was the Arrach and Lorlatinib combination checked?
Interactions in our licensed database are recorded against drug classes. Lorlatinib is filed under 3 classifications, and Arrach has documented interactions with 1 drug class — none of Lorlatinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Arrach interact with any other medications?
Yes. Arrach has 335 documented drug interactions in our database — Lorlatinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Lorlatinib interact with any supplements?
Yes. Lorlatinib has documented interactions with 153 supplements in our database — Arrach is not one of them. The Lorlatinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Lorlatinib and Arrach?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.